GEHC GE HealthCare
Intrinsic value$74.19
Price (at call)$68.86
Margin of safety
+7.7%
vs market (rating basis)
+69.7%
Model unavailable; showing baseline valuation.
⚠ LLM error: empty response; using baseline
The story
Value drivers
| Revenue growth (Y1) | 4.0% |
| Terminal growth | 3.5% |
| Forecast horizon | 10y |
| Target operating margin | 14.5% |
| Years to target margin | 5 |
| Sales-to-capital | 1.04 |
| Beta | 0.82 |
| Failure probability | 0.0% |
| Cost of capital (WACC) | 7.6% |
| Terminal WACC | 8.2% |
Valuation bridge
| PV of explicit FCFF | 13.75B |
| PV of terminal value | 25.71B |
| Equity value | 33.51B |
| ÷ shares → per share | $74.19 |
News
bullish +0.30 · 8 articles
- GE HealthCare (GEHC) Stock Looks Reasonable On Earnings Yet Weak On Market Read
- GEHC Wins CE Mark for Photonova Spectra, Expands International Reach
- GE HealthCare’s (GEHC) Latest Scanner Breakthrough Meets A Mixed Market
- GE HealthCare secures CE mark for Photonova Spectra CT system
- 1 S&P 500 Stock with Exciting Potential and 2 We Ignore
- GEHC vs. HAE: Which Stock Is the Better Value Option?
- GE HealthCare Unveils Next-Gen Vivid Cardiac Ultrasound Systems
- Why Is GE HealthCare (GEHC) Up 3.6% Since Last Earnings Report?
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 22.12B | 4.0% | 14.5% | 2.50B | 813.18M | 1.69B | 1.57B |
| 2 | 22.99B | 3.9% | 14.5% | 2.60B | 834.09M | 1.76B | 1.52B |
| 3 | 23.88B | 3.9% | 14.5% | 2.70B | 854.93M | 1.84B | 1.48B |
| 4 | 24.79B | 3.8% | 14.5% | 2.80B | 875.66M | 1.93B | 1.44B |
| 5 | 25.73B | 3.8% | 14.5% | 2.91B | 896.23M | 2.01B | 1.39B |
| 6 | 26.68B | 3.7% | 14.5% | 3.02B | 916.63M | 2.10B | 1.35B |
| 7 | 27.66B | 3.7% | 14.5% | 3.13B | 936.79M | 2.19B | 1.31B |
| 8 | 28.66B | 3.6% | 14.5% | 3.24B | 956.68M | 2.28B | 1.27B |
| 9 | 29.68B | 3.6% | 14.5% | 3.35B | 976.26M | 2.38B | 1.23B |
| 10 | 30.72B | 3.5% | 14.5% | 3.47B | 995.49M | 2.48B | 1.19B |